Cookie Policy

Mereo BioPharma Group plc's website uses cookies. By continuing to browse you are agreeing to our use of cookies. Find out more about our Cookie Policy.

MREO: US$2.61 MPH: 39.50GBp
Mereo-Banner-Image.jpg

Working together to inspire, innovate and improve lives

See our latest news

News

20 Oct 2020 Additions to Management Team
19 Oct 2020 Mereo Announces FDA Clearance for Phase 1b/2 Etigilimab Anti-TIGIT Study
29 Sep 2020 Interim Financial Results for the Six Months Ended June 30, 2020 and Corporate Update
Press Releases

View our latest Corporate Presentation

section-img.jpg
1 OCT 2020 Corporate Presentation
8 MAY 2020 View the Events and Conferences we are attending Events and Conferences
profile-img.jpg
quote.svg

We continue to make strong progress in development of our product portfolio, in the hope of providing better treatment options for patients suffering from rare diseases

Denise Scots-Knight, CEO Our Mission